PCV2 - Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany: A Population-Based Modelling Study. - Mueller, M; Himmler, S; Basic, E; Hradetzky, E (Value in Health, 2017)